Letter to the editor regarding "Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable".
作者信息
Magrini Stefano Maria, Katz Matthew S, Tomasini Davide, Sasso Giuseppe, Triggiani Luca, Buglione di Monale E Bastia Michela, Spiazzi Luigi
机构信息
Radiation Oncology Department, ASST Spedali Civili di Brescia - Brescia University, Italy.
Department of Radiation Medicine, Lowell General Hospital, Lowell, USA.
出版信息
Radiother Oncol. 2020 Sep;150:172-173. doi: 10.1016/j.radonc.2020.06.034. Epub 2020 Jul 1.
Abstract
摘要
相似文献
1
Letter to the editor regarding "Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable".致编辑的信：关于“缺乏支持数据使得放射治疗作为新冠肺炎肺炎治疗方法的临床试验风险不可接受”
Radiother Oncol. 2020 Sep;150:172-173. doi: 10.1016/j.radonc.2020.06.034. Epub 2020 Jul 1.
2
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable.缺乏支持性数据使得将放射治疗作为新冠肺炎肺炎治疗方法的临床试验风险不可接受。
Radiother Oncol. 2020 Jun;147:217-220. doi: 10.1016/j.radonc.2020.04.060. Epub 2020 May 12.
3
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.COVID-19 肺炎的糖皮质激素（CORTIVID）治疗：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.
4
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.沙利鲁单抗对比标准治疗用于住院 COVID-19 肺炎患者的早期治疗：SARTRE：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Sep 16;21(1):794. doi: 10.1186/s13063-020-04633-3.
5
Letter to the Editor Regarding "Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era".致编辑的信：关于“致编辑的信：COVID-19 时代的脊柱与神经外科出版物”
World Neurosurg. 2020 Nov;143:613. doi: 10.1016/j.wneu.2020.08.034.
6
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.多臂试验炎症信号抑制剂（MATIS）治疗 COVID-19 轻症或中度肺炎住院患者：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 12;22(1):270. doi: 10.1186/s13063-021-05190-z.
7
COVID-19 letter to the editor: Epicardial fat inflammation as possible enhancer in COVID-19?致编辑的关于COVID-19的信：心外膜脂肪炎症是否可能是COVID-19病情加重的因素？
Metabolism. 2021 Apr;117:154722. doi: 10.1016/j.metabol.2021.154722. Epub 2021 Feb 4.
8
Interim Analysis of Impact of Adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 Pneumonia Patients: IMpaCt-RT Study.低剂量肺部放疗对中度新冠肺炎肺炎患者影响的中期分析：IMpaCt-RT研究
Front Oncol. 2022 Mar 29;12:822902. doi: 10.3389/fonc.2022.822902. eCollection 2022.
9
The risk of induced cancer and ischemic heart disease following low dose lung irradiation for COVID-19: estimation based on a virtual case.低剂量肺部照射治疗 COVID-19 后引发癌症和缺血性心脏病的风险：基于虚拟病例的估计。
Int J Radiat Biol. 2021;97(2):120-125. doi: 10.1080/09553002.2021.1846818. Epub 2020 Nov 17.
10
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.一项评估巴瑞替尼预防 COVID19 相关血液肿瘤患者呼吸功能不全进展的疗效的 I/II 期临床试验：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4.
引用本文的文献
1
Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial.低剂量肺部放射治疗 COVID-19 相关肺炎：意大利单机构 COLOR-19 试验的初步结果。
In Vivo. 2022 Jul-Aug;36(4):1959-1965. doi: 10.21873/invivo.12918.
2
Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.低剂量辐射可增加病毒感染和肺炎期间肺巨噬细胞的免疫抑制特性。
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1283-1294. doi: 10.1016/j.ijrobp.2021.03.022. Epub 2021 Mar 13.
本文引用的文献
1
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
2
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
3
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子（包括白细胞介素 6）在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
4
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
5
COVID-19 and Italy: what next?COVID-19 和意大利：下一步如何？
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
6
Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose.放射性治疗在人类炎症性疾病和病症中的应用：最佳剂量。
Hum Exp Toxicol. 2019 Aug;38(8):888-898. doi: 10.1177/0960327119846925. Epub 2019 May 6.
7
Re-evaluation of the linear no-threshold (LNT) model using new paradigms and modern molecular studies.重新评估新范式和现代分子研究的线性无阈（LNT）模型。
Chem Biol Interact. 2019 Mar 1;301:54-67. doi: 10.1016/j.cbi.2018.11.013. Epub 2019 Feb 11.
8
How radiotherapy was historically used to treat pneumonia: could it be useful today?历史上如何用放射疗法治疗肺炎：今天它还会有用吗？
Yale J Biol Med. 2013 Dec 13;86(4):555-70.
9
Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved.低剂量放疗的抗炎作用。适应证、剂量和涉及的放射生物学机制。
Strahlenther Onkol. 2012 Nov;188(11):975-81. doi: 10.1007/s00066-012-0170-8. Epub 2012 Aug 22.
Zotero 插件